3rd Quarter - Report

TODD STRATEGY GROUP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

340B Program. Home Infusion for Part B Products. Medicare Reimbursement for New Technologies.

LobbyistCovered position, as disclosed
ERIC BERGREN Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
KATHERINE FLEMING COTTON Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
PAUL EDATTEL Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
TED LEHMAN Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant
DANIEL M TODD Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

General issues related to rare disease and orphan drugs. Diagnostics for patients with rare disease. Multi-Cancer Early Detection.

LobbyistCovered position, as disclosed
ERIC BERGREN —
KATHERINE FLEMING COTTON —
PAUL EDATTEL —
TED LEHMAN —
DANIEL M TODD —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.